This chemical, 4-(N-(Butylcarbamoyl)sulfamoyl)benzoic acid, is primarily used as a key intermediate in the synthesis of sulfonylurea-based pharmaceuticals, particularly antidiabetic drugs for type 2 diabetes that stimulate insulin release from pancreatic beta cells and improve insulin sensitivity. It is also employed in the development of other sulfonamide derivatives with antimicrobial, diuretic, or enzyme-inhibiting properties. In research, it aids in studying biological interactions of sulfonamides. Additionally, its applications extend to agrochemical production, contributing to herbicides and pesticides. The compound's sulfonylurea-like structure enables effective interactions with biological targets in therapeutic and agricultural contexts.